Global Data Flows and the Implications for Health Access in Developing Countries

Subtitle

featuring HLS Professor Mark Wu

Teaser

What types of policies concerning cross-border data flows should developing countries be adopting and advocating to safeguard their interests, particularly with respect to health care?

Event Date

Jul
24
2017
12:00pm

to

Jul
24
2017
12:00pm

Thumbnail Image: 

Monday, July 24, 2017
12:00pm – 1:30pm

Harvard Global Health Institute Conference Room
42 Church St. Cambridge, MA 02138RSVP required

*/

Global Access in Action: Conversations in Global Health, Innovation, & the Digital World

This event is being sponsored by the Harvard Global Health Institute and the Berkman Klein Center for Internet & Society at Harvard University.

Governments around the world are increasingly regulating the flow of cross-border data on the basis of privacy, security, and other public interest concerns. These policies take on a variety of forms, such as data localization requirements and obligations for service providers to make data available to law enforcement authorities under certain circumstances. What types of policies concerning cross-border data flows should developing countries be adopting and advocating to safeguard their interests, particularly with respect to health care? Join us for an open discussion.

About Global Access in Action
Global Access in Action, a project of the Berkman Klein Center for Internet & Society at Harvard University, conducts action-oriented research into access to lifesaving medicines, and alternative incentives for the development of medical treatments for underserved populations. Improving access and promoting socially beneficial innovation are key strategies for combatting the communicable disease burden that disproportionately harms the world’s most vulnerable populations.

About the GAiA Brown Bag Series
The GAiA brown bag series, "Conversations in Global Health, Innovation & the Digital World," is a collaboration with the Harvard Global Health Institute to facilitate discussion among researchers, scholars, practitioners, and others engaged in the development of legal and policy frameworks that govern innovation and global commercialization of medicines. The next brown bag event will be July 31st, and will feature GAiA Affiliate John Stubbs discussing Trump's America First Trade Agenda: What It Means for Access to Medicines.

About Mark Wu
Mark Wu is an Assistant Professor of Law at Harvard Law School and a Director of the Berkman Klein Center. His work focuses on international trade and international intellectual property matters.

Prior to joining HLS the faculty in 2010, Mark Wu was an Academic Fellow at Columbia Law School and a law clerk to Judge Pierre N. Leval of the U.S. Court of Appeals for the Second Circuit. He has served as the Director for Intellectual Property in the Office of the U.S. Trade Representative, where he led negotiations on the IP chapters of various free trade agreements. In addition, he worked as an engagement manager for McKinsey & Co., as an economist and operations officer for the World Bank in China, and as an economist for the United Nations Development Programme in Namibia.

Related Content: Global Access in Action